EVD Drainage Data and Intracranial Pressure (ICP) Measurements

Exploratory outcome

Rhaeos, Inc. is initially targeting hydrocephalus, a life threatening condition caused by an
 abnormal accumulation of cerebrospinal fluid (CSF). Implantable shunts, the gold standard
 treatment, often fail, leading to multiple trips to the emergency room and repeat surgeries.
 There is no technology available today that can easily assess CSF flow in shunts wirelessly,
 bedside, and without capital equipment until now.
 
 FlowSense, is a wireless, noninvasive thermal flow sensor that can be mounted on a patient's
 neck overlying the shunt to detect the presence and magnitude of CSF. Similar in size to a
 bandage, it is composed of soft, silicone with no hard edges. Data is wirelessly transmitted
 to a custom designed mobile app. With FlowSense, monitoring of shunt function can occur in
 clinics, in-patient settings, and emergency departments, thereby reducing unnecessary
 imaging, hospital length of stay, and readmission costs.